TRAK2 and breast cancer: Consistent with these observations, different outcomes were able to demonstrate the mechanism adopted by breast cancer cells which interfere in the small GTPase Arf6 -based pathway inducing the localization of ILK to focal adhesions to block RhoT1-TRAK2 association, which controls mitochondrial retrograde trafficking [42,43].